Ozempic User Reviews & Ratings
Ozempic has an average rating of 6.4 out of 10 from a total of 1,102 reviews on Drugs.com. 51% of reviewers reported a positive experience, while 27% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Diabetes, Type 2 | 901 reviews for Diabetes, Type 2 | 152 medications | |
Cardiovascular Risk Reduction | 201 reviews for Cardiovascular Risk Reduction | 23 medications | |
Add your review |
Reviews for Ozempic
- chauvin
- Taken for 6 months to 1 year
- April 4, 2023
For Diabetes, Type 2 "I lost 7 kgs and reduced my insulin intake by 35%. Secondary effects bloating, and delay of transit hypoglycemia."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Ozempic (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: Incretin Mimetics (GLP-1 Agonists)
- Breastfeeding
- En español
For Diabetes, Type 2 "Had my third spinal operation in December 2018, a multi level fusion. Doctors wanted me to lose weight and because I couldn’t exercise I was prescribed ozempic. I had previously been on victoza which was awful with terrible hypoglycemia and little weight loss. Ozempic has allowed me to totally control my food cravings and intake, I lost 40lbs in under 6 months doing little or no exercise and eating way less without feeling hungry. I have had almost no side effects, besides fleeting nausea maybe once every second day. Really works for me however I’m now on it 7 months and I’m finding the 1mg dose is not as effective as it once was."